Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1999 | 12-1998 | 09-1998 | 06-1998 | 03-1998 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 16,940 | 23,030 | 18,670 | 12,410 | 14,920 |
| TOTAL | $16,940 | $23,030 | $18,670 | $12,410 | $14,920 |
| Non-Current Assets | |||||
| PPE Net | 281,350 | 280,950 | 300,420 | 269,610 | 264,640 |
| Investments And Advances | 0 | 28,650 | 0 | 22,510 | 17,400 |
| Other Non-Current Assets | 69,800 | 40,890 | 39,030 | 38,640 | 38,630 |
| TOTAL | $351,150 | $350,490 | $339,450 | $330,760 | $320,670 |
| Total Assets | $368,090 | $373,520 | $358,120 | $343,170 | $335,590 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 49,830 | 81,340 | 67,690 | 27,500 | 17,330 |
| Accounts payable and accrued liabilities | 17,820 | 22,370 | 20,160 | 22,340 | 14,460 |
| Accrued Expenses | 2,760 | 3,570 | 2,140 | 2,770 | 2,990 |
| TOTAL | $94,800 | $115,400 | $107,540 | $60,670 | $45,750 |
| Non-Current Liabilities | |||||
| TOTAL | $75,400 | $75,380 | $70,230 | $69,090 | $68,280 |
| Total Liabilities | $170,200 | $190,780 | $177,770 | $129,760 | $114,030 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 52,040 | 0 | 50,350 | 48,900 |
| TOTAL | $N/A | $87,560 | $N/A | $77,230 | $73,470 |
| Total Liabilities And Equity | $170,200 | $278,340 | $177,770 | $206,990 | $187,500 |